The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Neglected Tropical Disease Treatment Market During The Forecast Period?
The size of the neglected tropical disease treatment market has witnessed significant growth over the past few years. This market is anticipated to expand from $3.57 billion in 2025 to $3.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this historical growth include the enduring prevalence of these diseases in tropical regions, robust support from global health organizations, the broadening scope of donor-funded treatment programs, the accessibility of generic therapeutics, and intensified public health awareness campaigns.
The neglected tropical disease treatment market size is projected to show robust expansion in the upcoming years, with an anticipated rise to $4.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is fueled by factors such as escalating investments in eradication programs, the increasing adoption of integrated disease management approaches, the broadening scope of novel antiparasitic drug development, the proliferation of public-private partnerships, and a greater concentration on healthcare access in remote regions. Significant trends anticipated over the forecast timeframe include the wider deployment of combination drug therapies, a heightened focus on early disease detection initiatives, the expanding utilization of mass drug administration strategies, the growth of community-based treatment models, and an intensified emphasis on treatment accessibility.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp
What Leading Drivers Are Supporting The Neglected Tropical Disease Treatment Market Expansion?
The expanding occurrence of infectious diseases is anticipated to propel the neglected tropical disease treatment market going forward. Infectious diseases are defined as ailments resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of spreading from person to person either directly or indirectly. The increased prevalence of these diseases is linked to more extensive travel, which facilitates the swift dispersion of pathogens across borders. Neglected tropical disease treatment supports the management of infectious diseases by offering targeted therapies aimed at controlling and eradicating disease transmission. These therapeutic approaches improve public health outcomes, especially for vulnerable communities, by decreasing the disease load and preventing long-term disabilities. For example, in February 2024, the UK Health Security Agency, a UK-based government organization, reported that tuberculosis cases in England reached 4,850 in 2023, marking a 10.7% increase from 4,380 cases in 2022. Thus, the growing prevalence of infectious diseases is driving the growth of the neglected tropical disease treatment market.
How Are Segments Identified Within The Neglected Tropical Disease Treatment Market Segment Framework?
The neglected tropical disease treatment market covered in this report is segmented –
1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class
2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides
2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins
3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides
4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments
What Emerging Trends Are Seen In The Neglected Tropical Disease Treatment Market?
Major companies operating in the neglected tropical disease treatment market are concentrating on developing innovative solutions, such as all-oral, field-deployable therapeutics, to simplify administration, improve safety, and expand access in low-resource settings. All-oral therapeutics for diseases like human African trypanosomiasis involve small-molecule drugs administered orally over a short course, which helps improve treatment reach, reduce the need for hospitalization, and lower operational barriers compared with traditional injectable therapies. For instance, in December 2023, Sanofi S.A., a France-based multinational pharmaceutical company, introduced Fexinidazole Winthrop, an oral treatment developed in partnership with not-for-profit organizations. Fexinidazole is a nitro-containing small molecule designed to replace older regimens requiring intravenous delivery or hospitalization. Its oral formulation, simplified dosing schedule, and favorable safety profile make it suitable for use across both stages of certain forms of sleeping sickness, expanding treatment access in remote settings. Furthermore, Fexinidazole contrasts with traditional alternatives such as melarsoprol and eflornithine, which are injectable, require complex monitoring, and have higher toxicity or operational challenges.
Who Are The Companies Competing Within The Neglected Tropical Disease Treatment Market?
Major companies operating in the neglected tropical disease treatment market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Eisai Co Ltd, Shionogi And Co Ltd, Dr Reddys Laboratories Ltd, Cipla Ltd, Gilead Sciences Inc, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Alvogen
Get The Full Neglected Tropical Disease Treatment Market Report:
Where Is The Neglected Tropical Disease Treatment Market Most Concentrated Geographically?
Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2025. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neglected Tropical Disease Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Neglected Tropical Disease Treatment Market 2026, By The Business Research Company
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Market Report 2026
Pain Management Devices And Therapies Market Report
Defibrillator Devices And Equipment Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model